Zoetis

Deloitte Consulting Becomes First Corporate Member of T200

Retrieved on: 
Thursday, March 30, 2023

NEW YORK, March 30, 2023 /PRNewswire/ -- Deloitte Consulting announced today that they will join T200, a not-for-profit, volunteer-based organization for women in technology, to help elevate women as executive and C-suite technology leaders.

Key Points: 
  • Deloitte Consulting will join T200 in fostering, celebrating, and advancing women's leadership in tech
    NEW YORK, March 30, 2023 /PRNewswire/ -- Deloitte Consulting announced today that they will join T200 , a not-for-profit, volunteer-based organization for women in technology, to help elevate women as executive and C-suite technology leaders.
  • "Since its inception, T200 has been making a significant impact, supporting women in leadership roles.
  • Deloitte's CIO Program has been empowering professional development and inclusion for women in IT since the program's inception in 2012.
  • We are committed to  helping advance diversity and inclusion in tech leadership roles that are critical to realizing the growth ambitions of their organizations," said Kristen Stuart, U.S. consulting strategy leader , and principal, Deloitte Consulting LLP.

Zoetis Named One of the World’s Most Ethical Companies by Ethisphere

Retrieved on: 
Monday, March 13, 2023

Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies .

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies .
  • Zoetis is one of three pharmaceutical companies and the only standalone animal health company included on the list.
  • “We are truly honored to be recognized by Ethisphere on their prestigious World’s Most Ethical Companies list,” said Kristin Peck, CEO of Zoetis.
  • Ethisphere’s 2023 Ethics Index, the collection of publicly traded companies recognized as recipients of this year’s World’s Most Ethical Companies designation, outperformed a comparable index of large-cap companies by 13.6 percentage points over a five-year period.

Zoetis to Participate in the TD Cowen Health Care Conference

Retrieved on: 
Friday, March 3, 2023

Zoetis Inc. (NYSE:ZTS) will participate in the TD Cowen Health Care Conference on Monday, March 6, 2023.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the TD Cowen Health Care Conference on Monday, March 6, 2023.
  • Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

Zoetis to Participate in the Bank of America Securities 2023 Animal Health Summit

Retrieved on: 
Tuesday, February 28, 2023

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2023 Animal Health Summit on Thursday, March 2, 2023.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2023 Animal Health Summit on Thursday, March 2, 2023.
  • Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

Elanco Adds Animal Health Veteran to Executive Committee

Retrieved on: 
Monday, February 20, 2023

Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development.

Key Points: 
  • Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development.
  • Tim has built some of the industry’s most successful portfolios and overseen some of the most significant commercial businesses in animal health.
  • Prior to Zoetis, he served as North American Region Head of Commercial Operations for Boehringer Ingelheim’s animal health business.
  • In roles at Zoetis, Boehringer Ingelheim and Novartis Animal Health, Bettington developed deep expertise in sales excellence, product launch, strategy and business integration.

Zoetis Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Tuesday, February 14, 2023

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023.
  • The company reported revenue of $2.0 billion for the fourth quarter of 2022, which was an increase of 4% compared with the fourth quarter of 2021.
  • On an operational1 basis, revenue for the fourth quarter of 2022 increased 9% compared with the fourth quarter of 2021, excluding the impact of foreign currency.
  • Adjusted net income2 for the fourth quarter of 2022 increased 27% operationally, excluding the impact from foreign currency.

Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend

Retrieved on: 
Monday, February 6, 2023

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, effective immediately.

Key Points: 
  • The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, effective immediately.
  • His appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors.
  • Prior to Mars, Mr. Bernal worked 17 years for Zoetis (formerly Pfizer Animal Health), and was a member of the Executive Team for 10 years.
  • Mr. Bernal is qualified to serve on our Board of Directors due to his extensive management and leadership experience in all facets of the animal health industry, including in corporate strategy and business development.

PetDx Appoints Alejandro Bernal as its New President and Chief Executive Officer

Retrieved on: 
Tuesday, January 24, 2023

SAN DIEGO, Jan. 24, 2023 /PRNewswire/ -- PetDx® – The Liquid Biopsy Company for Pets™ announced today that Alejandro Bernal, DVM, MS, MBA, has been appointed as its new President and Chief Executive Officer. An experienced industry executive, Bernal will succeed PetDx Founder Daniel S. Grosu, MD, MBA, who will continue in his role as Chairman of the Board.

Key Points: 
  • SAN DIEGO, Jan. 24, 2023 /PRNewswire/ -- PetDx® – The Liquid Biopsy Company for Pets™ announced today that Alejandro Bernal, DVM, MS, MBA, has been appointed as its new President and Chief Executive Officer.
  • An experienced industry executive, Bernal will succeed PetDx Founder Daniel S. Grosu, MD, MBA, who will continue in his role as Chairman of the Board.
  • "Alejandro Bernal is one of the most respected leaders in the animal health industry, with extensive experience in driving transformative investment agendas and building unique, differentiated, and fast-growing businesses," Grosu said.
  • "We are excited that he brings that experience and passion to PetDx and to OncoK9®, the first and only genomics-based multi-cancer early detection test in veterinary medicine."

Women Leaders in Animal Health Industry Recognized with 6th Annual Feather in Her CapSM Awards

Retrieved on: 
Tuesday, January 17, 2023

More than 250 attended the sixth annual Feather in Her Cap Award celebration on January 16, 2023, recognizing women leaders in the animal health industry for their significant contributions.

Key Points: 
  • More than 250 attended the sixth annual Feather in Her Cap Award celebration on January 16, 2023, recognizing women leaders in the animal health industry for their significant contributions.
  • Two awards were given this year, the Feather in Her Cap Award and the High Flyer Award.
  • View the full release here: https://www.businesswire.com/news/home/20230117006162/en/
    The 2023 Feather in Her Cap Award was given to Dr. Véronique Kodjo, a leader in global manufacturing, supply chain and quality in the animal health industry.
  • (Photo: Business Wire)
    The 2023 Feather in Her Cap Award was given to Dr. Véronique Kodjo, a leader in global manufacturing, supply chain and quality in the animal health industry.

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, December 22, 2022

(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023.

Key Points: 
  • (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023.
  • Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2022 financial results and respond to questions from financial analysts during the call.
  • Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations .
  • A replay of the webcast will be made available on Feb. 14, 2023.